A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.

Autor: Kosmas, Christos, Tsavaris, Nicolas B., Makatsoris, Thomas, Onyenadum, Adimchi, Vadiaka, Maria, Stavroyianni, Niki, Sepsas, Evangelos, Dimitropoulos, Dimitris, Rokana, Sofia, Kalofonos, Haralambos P.
Zdroj: International Journal of Cancer; Mar2002, Vol. 98 Issue 1, p141-147, 7p
Databáze: Complementary Index
Externí odkaz: